Elixxer Overview
- Year Founded
-
2004
- Status
-
Public
- Stock Symbol
-
ELXR.H
- Investments
-
9
- Share Price
-
$0.01
- (As of Friday Closing)
Elixxer General Information
Description
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.
Contact Information
Website
www.elixxer.comCorporate Office
- 800 Place Victoria
- Suite 3700
- Montreal, Quebec H4Z 1E9
- Canada
Corporate Office
- 800 Place Victoria
- Suite 3700
- Montreal, Quebec H4Z 1E9
- Canada
Elixxer Stock Performance
As of 13-Nov-2026, Elixxer’s stock price is $0.01. Its current market cap is $1.34M with 95.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.03 | $0.01 - $0.06 | $1.34M | 95.3M | 3.42K | -$0.18 |
Elixxer Financials Summary
As of 30-Jun-2026, Elixxer has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 9,272 | 10,295 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,195) | (910) | (1,038) | |
| Net Income | (2,449) | (2,771) | (2,528) | (2,968) |
| Total Assets | 718 | 777 | 1,487 | 2,116 |
| Total Debt | 7,414 | 7,212 | 8,301 | 7,280 |
Elixxer Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Elixxer Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Elixxer Investments & Acquisitions (9)
Elixxer’s most recent deal was a Secondary Transaction - Private with Little Green Pharma. The deal was made on 26-Aug-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Little Green Pharma | 26-Aug-2019 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology | ||
| Freia Farmaceutici | 29-Jul-2019 | Later Stage VC | Drug Discovery | ||
| Viridi Unit | 12-Dec-2018 | Corporate | Cultivation | ||
| EasyJoint | 12-Nov-2018 | Corporate | Pharmaceuticals | ||
| CLV Frontier Brands | 11-Jan-2018 | Joint Venture | Beverages |
Elixxer ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Diversified Financials
Industry
Rank
Percentile
Asset Management and Custody Services
Subindustry
Rank
Percentile
Elixxer Exits (1)
Elixxer’s most recent exit was on 12-Dec-2018 from Viridi Unit. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Viridi Unit | 12-Dec-2018 | Completed |
|
Elixxer FAQs
-
When was Elixxer founded?
Elixxer was founded in 2004.
-
Where is Elixxer headquartered?
Elixxer is headquartered in Montreal, Canada.
-
What industry is Elixxer in?
Elixxer’s primary industry is Other Financial Services.
-
Is Elixxer a private or public company?
Elixxer is a Public company.
-
What is Elixxer’s stock symbol?
The ticker symbol for Elixxer is ELXR.H.
-
What is the current stock price of Elixxer?
As of 13-Nov-2026 the stock price of Elixxer is $0.01.
-
What is the current market cap of Elixxer?
The current market capitalization of Elixxer is $1.34M.
-
What is Elixxer’s annual earnings per share (EPS)?
Elixxer’s EPS for 12 months was -$0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process